Histology of nerves and muscles in adductor spasmodic dysphonia

Annals of Otology, Rhinology and Laryngology

Volumn 112, Issue 4, 2003, Pages 334-341

  Chhetri, Dinesh K ^a   Blumin, Joel H ^a   Vinters, Harry V ^b   Berke, Gerald S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

Histology; Muscle; Nerve; Pathophysiology; Spasmodic dysphonia

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRICOARYTENOID MUSCLE; DYSPHONIA; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LARYNX MUSCLE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE SPASM; MYELINATED NERVE; NERVE BIOPSY; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE; SPASMODIC DYSPHONIA;

EID: 0037387455     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940311200407     Document Type: Article

References (32)

1. Aronson AE, Brown JR, Litin EM, Pearson JS. Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias. J Speech Hear Disord 1968;33:219-31.
2. Blitzer A, Lovelace RE, Brin MF, Fahn S, Fink ME. Electromyographic findings in focal laryngeal dystonia (spastic dysphonia). Ann Otol Rhinol Laryngol 1985;94:591-4.
3. Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98:636-40.
4. Finitzo-Hieber T, Freeman FJ, Gerling IJ, Dobson L, Schaefer SD. Auditory brainstem response abnormalities in adductor spasmodic dysphonia. Am J Otolaryngol 1982;3:26-30.
5. Bielamowicz S, Ludlow CL. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000;109:194-203.
6. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451-9.
7. Ludlow CL. Treatment of speech and voice disorders with botulinum toxin. JAMA 1990;264:2671-5.
8. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001;111:218-26.
9. Isshiki N, Tsuji DH, Yamamoto Y, Iizuka Y. Midline lateralization thyroplasty for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000;109:187-93.
10. Berke GS, Blackwell KE, Gerratt BR, Verneil A, Jackson KS, Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999;108:227-31.
11. Schweizer V, Dorfl J. The anatomy of the inferior laryngeal nerve. Clin Otolaryngol 1997;22:362-9.
12. Nguyen M, Junien-Lavillauroy C. Anatomy of the larynx, study of the anterior branch of the recurrent laryngeal nerve. Rev Laryngol Otol Rhinol (Bord) 1990;111:153-5.
13. Dubowitz V, Brooke MH. Muscle biopsy: a modem approach. Philadelphia, Pa: WB Saunders, 1973.
14. Hillel AD. The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple fine-wire electromyography. Laryngoscope 2001; 111(suppl 97).
15. Barany M. ATPase activity of myosin correlated with speed of muscle shortening. J Gen Physiol 1967;50(suppl):197-218.
16. Teig E, Dahl HA, Thorkelsen H. Actomyosin ATPase activity of human laryngeal muscles. Acta Otolaryngol (Stockh) 1978;85:272-81.
17. Malmgren LT, Gacek RR. Histochemical characteristics of muscle fiber types in the posterior cricoarytenoid muscle. Ann Otol Rhinol Laryngol 1981;90:423-9.
18. Rosenfield DB, Miller RH, Sessions RB, Patten BM. Morphologic and histochemical characteristics of laryngeal muscle. Arch Otolaryngol 1982;108:662-6.
19. Porter JD, Strebeck S, Capra NF. Botulinum-induced changes in monkey eyelid muscle. Comparison with changes seen in extraocular muscle. Arch Ophthalmol 1991;109:396-404.
20. Horn AK, Porter JD, Evinger C. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics. Exp Brain Res 1993;96:39-53.
21. Harris CP, Alderson K, Nebeker J, Holds JB, Anderson RL. Histologic features of human orbicularis oculi treated with botulinum A toxin. Arch Ophthalmol 1991;109:393-5.
22. Duchen LW. Effects of botulinum toxin on the distribution of succinate dehydrogenase and phosphorylase in fast and slow skeletal muscles of the mouse. J Neurol Neurosurg Psychiatry 1970;33:580-5.
23. Duchen LW. An electron microscopic study of changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 1971; 14:47-60.
24. Duchen LW. Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin. J Neurol Sci 1971;14:61-74.
25. Kranjc BS, Sketelj J, D'Albis A, Erzen I. Long-term changes in myosin heavy chain composition after botulinum toxin A injection into rat medial rectus muscle. Invest Ophthalmol Vis Sci 2001;42:3158-64.
26. Romanul FC, Van der Meulen JP. Reversal of the enzyme profiles of muscle fibres in fast and slow muscles by cross-innervation. Nature 1966;212:1369-70.
27. Yellin H. Neural regulation of enzymes in muscle fibers of red and white muscle. Exp Neurol 1967;19:92-103.
28. Telerman-Toppet N, Bacq M, Khoubesserian P, Coers C. Type 2 fiber predominance in muscle cramp and exertional myalgia. Muscle Nerve 1985;8:563-7.
29. Edstrom L, Kugelberg E. Histochemical mapping of motor units in experimentally re-innervated skeletal muscle. Experientia 1969;25:1044-5.
30. Dedo HH, Izdebski K, Townsend JJ. Recurrent laryngeal nerve histopathology in spastic dysphonia: a preliminary study. Ann Otol Rhinol Laryngol 1977;86:806-12.
31. Carlsoo B, Izdebski K, Dahlqvist A, Domeij S, Dedo HH. The recurrent laryngeal nerve in spastic dysphonia. A light and electron microscopic study. Acta Otolaryngol (Stockh) 1987; 103:96-104.
32. Kosaki H, Iwamura S, Yamazaki I. Histologic study of the recurrent laryngeal nerve in spasmodic dysphonia. Otolaryngol Head Neck Surg 1999;120:129-33.